(Updated - March 2, 2026 7:21 AM EST)

Stephens analyst Sudan Loganathan raised the price target on Kymera Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE